Quintiles says payers driving demand for market access offering

By Gareth Macdonald

- Last updated on GMT

Related tags: Market access, Clinical trial

US CRO Quintiles says healthcare payer influence is driving pharmaceutical industry demand for market access services.

Quintiles’ comments follow its acquisition of specialist US contract marketing firm VCG & Associates last week, which was the second time contract research organisation (CRO) has made an acquisition in the market access space this year​.

Spokeswoman Laura Wilson told Outsourcing-pharma.com: “Growth in demand for market access services is driven by the increasing influence of payers in health care decision making.

Wilson explained that: "Payers must make complex decisions about a particular drug based on its safety, efficacy and value. They are increasingly relying on data collected from patients in real world settings in addition to clinical trial data to inform that decision-making​.”

She added that: “VCG brings expertise across therapeutic areas, contacts throughout health care providers, and expertise in the development and implementation of sales and marketing efforts​.”

Competitive concerns not a worry

Quintiles also rejected the idea – put forward in a recent survey​ reported by Outsourcing-pharma.com – that pharmaceutical industry clients’ competitive concerns are limiting the growth of the market access sector.

Our experience is that more customers are looking to outsource in the market access space. This includes smaller biotechs which may only have one brand and therefore do not have the requirement for a market access capability as well as medium to large pharma who are seeking flexibility and therapeutic expertise outside of their core specialties.​ “

Wilson added that: “Intellectual property remains with the customer and as an outsourcing company we have a relentless commitment to business ethics.”

Quintiles contention about increasing demand fits with developments in the wider contract services sector which has, over the last 12 months, seen competitors like Icon​ and INC Research​ both make acquisitions in the sector.

More recently AmerisourceBergen has been building capabilities in the field with the acquisition of reimbursement consultancies Premier Source​ and Theracom​.

Related news

Show more

Related products

Local lab Data Management

Local lab Data Management

Q² Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q² Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Related suppliers

Follow us


View more